| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |